Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Mutation Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Skin Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2017

Cancer immunotherapy in older patients

Marrone, K. A. & Forde, P. M. Jul 1 2017 In : Cancer Journal (United States). 23, 4, p. 219-222 4 p.

Research output: Contribution to journalReview article

Immunotherapy
Immune System
Neoplasms
Explosions
Clinical Trials

Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

Anagnostou, V. , Smith, K. N. , Forde, P. M. , Niknafs, N. , Bhattacharya, R. , White, J. , Zhang, T. , Adleff, V. , Phallen, J. , Wali, N. , Hruban, C. , Guthrie, V. B. , Rodgers, K. , Naidoo, J. , Kang, H. , Sharfman, W. , Georgiades, C. , Verde, F. , Illei, P. , Li, Q. K. & 9 others Gabrielson, E., Brock, M. V., Zahnow, C. A., Baylin, S. B., Scharpf, R. B., Brahmer, J. R., Karchin, R., Pardoll, D. M. & Velculescu, V. E. Mar 1 2017 In : Cancer Discovery. 7, 3, p. 264-276 13 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasms
T-Lymphocytes
Mutation
T-Cell Antigen Receptor

Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade

Naidoo, J., Cappelli, L. C., Forde, P. M., Marrone, K. A., Lipson, E. J., Hammers, H. J., Sharfman, W. H., Le, D. T., Baer, A. N., Shah, A. A., Albayda, J., Manno, R. L., Haque, U., Gutierrez, A. K., Bingham, C. O. & Brahmer, J. R. Jun 1 2017 In : Oncologist. 22, 6, p. 627-630 4 p.

Research output: Contribution to journalComment/debate

Characterization of 298 patients with lung cancer harboring MET Exon 14 skipping alterations

Schrock, A. B., Frampton, G. M., Suh, J., Chalmers, Z. R., Rosenzweig, M., Erlich, R. L., Halmos, B., Goldman, J., Forde, P., Leuenberger, K., Peled, N., Kalemkerian, G. P., Ross, J. S., Stephens, P. J., Miller, V. A., Ali, S. M. & Ou, S. H. I. 2016 In : Journal of Thoracic Oncology. 11, 9, p. 1493-1502 10 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Exons
Lung Neoplasms
Protein-Tyrosine Kinases
Gene Amplification

Familial GI stromal tumor with loss of heterozygosity and amplification of mutant KIT

Forde, P. M., Cochran, R. L., Boikos, S. A., Zabransky, D. J., Beaver, J. A., Meyer, C. F., Thornton, K. A., Montgomery, E. A., Lidor, A. O., Donehower, R. C. & Park, B. H. Jan 20 2016 In : Journal of Clinical Oncology. 34, 3, p. e13-e16

Research output: Contribution to journalArticle

Loss of Heterozygosity
Neoplasms